LobbyingMonticello Group, LLC on Behalf of Detroit Biopharma lobbying by quarter
Monticello Group, LLC on Behalf of Detroit Biopharma's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $25K. Its first report covers Q4 2025; the issues it reports most are Health Issues and Manufacturing.
Monticello Group, LLC on Behalf of Detroit Biopharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $25K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2025 | $10K | 1 |
| Q1 2026 | $15K | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$12.5K · 2 reports
- Manufacturing$12.5K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)2 reports
- Defense, Dept of (DOD)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Kamran Daravi Consulting | $25K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| KAMRAN DARAVI | U.S. Presidential Transition Team 2016-2017; Advisor for Global Affairs, U.S. Department of Health & Human Services 2017-2018; Senior Advisor, U.S. Dept. of State 2018-2019; Policy Advisor, Domestic Policy Council, The White House 2019-2021 | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Kamran Daravi Consulting | Under $5,000 |
| 07/16for Q4 2025 | Kamran Daravi Consulting | $10K |
| 04/20for Q1 | Kamran Daravi Consulting | $15K |
| 01/30for Q4 2025 | Kamran Daravi Consulting | $10K |
| 01/29for Q4 2025 | Kamran Daravi Consulting | Under $5,000 |